Multiple Sclerosis and Erectile Dysfunction: Prevalence, Mechanisms, and Management

Erectile dysfunction (ED) affects 50–75% of men with multiple sclerosis (MS) at some point.

Mechanisms

  • Neurogenic: Demyelination of spinal cord (T11–L2) and brainstem pathways mediating erection.
  • Vascular: Endothelial dysfunction, reduced NO bioavailability.
  • Medication side effects: Anticholinergics (oxybutynin), antidepressants (SSRIs), baclofen, opioids.
  • Psychological: Depression, anxiety, body image, relationship strain.
  • Fatigue/spasticity: Physical barriers to intimacy.

Evaluation

  • Detailed sexual history, IIEF questionnaire.
  • Review MS medications.
  • Nocturnal penile tumescence (NPT) or penile Doppler if vascular etiology suspected.

Treatment

  • PDE5 inhibitors (sildenafil, tadalafil): First-line; effective in neurogenic ED.
  • Vacuum erection device: Non-pharmacologic.
  • Intracavernosal injections (alprostadil): If PDE5i fail.
  • Penile implant: Definitive surgical option.
  • Medication adjustment: Switch offending agents.
  • Psychosexual counseling: Address mood, relationship, performance anxiety.
  • Pelvic floor PT: For spasticity/coordination.

Multidisciplinary approach (neurology, urology, psychology) yields best outcomes. ED is treatable; do not accept it as inevitable.

Multiple Sclerosis - Related Articles